Form 4: Kraig Biocraft COO Jonathan Rice Increases Stake Through Warrant Exercise
Insider Transaction Report
Kraig Biocraft Laboratories, Inc.'s Chief Operating Officer, Jonathan Rice, has increased his direct beneficial ownership by exercising warrants to acquire 314,636 shares of Class A Common Stock.
Summary
- Jonathan Richard Rice, Chief Operating Officer of Kraig Biocraft Laboratories, Inc. (KBLB), reported a change in beneficial ownership via an SEC Form 4 filing.
- On May 27, 2025, Mr. Rice acquired 314,636 shares of Class A Common Stock through the cashless exercise of 318,482 warrants.
- The exercise price for the warrants was $0.0828 per share.
- Following this transaction, Mr. Rice's direct beneficial ownership of Class A Common Stock stands at 5,692,836 shares.
- All 318,482 derivative securities (warrants) held by the reporting person were exercised, resulting in zero remaining warrants.
Sentiment
Score: 7
Explanation: The sentiment is positive due to an insider (COO) increasing their direct ownership in the company, which typically signals confidence in the company's future.
Positives
- The exercise of warrants by a key executive like the COO can signal confidence in the company's future prospects and valuation at the exercise price.
- An increase in insider ownership aligns the interests of management with those of shareholders.
Future Outlook
This document does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This Form 4 filing is a standard disclosure of an insider's change in beneficial ownership and does not provide broader industry context or trends.
Related Party Transactions
- The transaction involves an insider (Chief Operating Officer Jonathan Rice) acquiring shares from the company through the exercise of warrants, which is a common form of related party transaction in the context of executive compensation and ownership.
Stakeholder Impact
- Shareholders may view the increased insider ownership as a positive sign, potentially boosting investor confidence.
- Employees may perceive this as a sign of stability and belief in the company's long-term success from leadership.
Key Dates
| Date | Description |
|---|---|
| 05/28/2018 | Date warrants became exercisable |
| 05/27/2025 | Date of warrant exercise transaction |
| 05/28/2025 | Warrant expiration date |
| 05/29/2025 | Date Form 4 was signed by Reporting Person |
Keywords
Kraig Biocraft Laboratories, KBLB, Jonathan Rice, Chief Operating Officer, COO, Insider Transaction, Form 4, Beneficial Ownership, Warrant Exercise, Stock Acquisition, Cashless Exercise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.